Literature DB >> 24012102

High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker?

Yong-Ku Kim1, Kyoung-Sae Na, Jung-A Hwang, Ho-Kyoung Yoon, Heon-Jeong Lee, Sang-Woo Hahn, Bun-Hee Lee, Han-Yong Jung.   

Abstract

OBJECTIVES: Neurotrophic factors exert substantial effects on the central nervous system. The present study investigates the roles of insulin-like growth factor-1 (IGF-1), β-nerve growth factor (β-NGF), and brain-derived neurotrophic factor (BDNF) in bipolar disorder.
METHODS: Baseline levels of culture-stimulated IGF-1, β-NGF, and BDNF were compared in 116 patients with bipolar I disorder and 123 healthy controls. Neurotrophic factors were also compared in patients before and after 6 weeks of pharmacotherapy. A multivariate logistic regression analysis was used to investigate the influence of the neurotrophic factors analyzed in quartile form, in relation to confounding variables, such as age, sex, and body mass index.
RESULTS: IGF-1 was significantly higher in patients (mean=514.57, SD=259.78) than in healthy controls (mean=316.82, SD=270.00, p<0.0001) at baseline. Furthermore, higher levels of IGF-1 substantially increased the risk for bipolar I disorder. IGF-1 level was not significantly changed at 6-weeks (mean=506.41, SD=313.66). No changes in BDNF or β-NGF-1 levels were found following the 6-week treatment period. IGF-1 and β-NGF were negatively correlated in healthy controls, but not in patients. Severity of manic symptoms was not associated with any of the neurotrophic factors. LIMITATIONS: We did not measure cortisol, growth hormone, or IGF-1 receptors. This study is cross-sectional in design.
CONCLUSIONS: Elevated IGF-1 levels may be a trait marker for bipolar disorder. Further studies are needed to thoroughly investigate the role of IGF-1 in relation to other neuroendocrine factors and biological markers for bipolar disorder.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Brain-derived neurotrophic factor; Insulin-like growth factor-1; Nerve growth factor; Neurotrophin

Mesh:

Substances:

Year:  2013        PMID: 24012102     DOI: 10.1016/j.jad.2013.07.041

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.

Authors:  Elena Milanesi; Adva Hadar; Elisabetta Maffioletti; Haim Werner; Noam Shomron; Massimo Gennarelli; Thomas G Schulze; Marta Costa; Maria Del Zompo; Alessio Squassina; David Gurwitz
Journal:  J Mol Neurosci       Date:  2015-03-05       Impact factor: 3.444

2.  Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review.

Authors:  Yen-Wen Chen; Pao-Yen Lin; Kun-Yu Tu; Yu-Shian Cheng; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

3.  Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.

Authors:  Brisa S Fernandes; Marc L Molendijk; Cristiano A Köhler; Jair C Soares; Cláudio Manuel G S Leite; Rodrigo Machado-Vieira; Thamara L Ribeiro; Jéssica C Silva; Paulo M G Sales; João Quevedo; Viola Oertel-Knöchel; Eduard Vieta; Ana González-Pinto; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2015-11-30       Impact factor: 8.775

Review 4.  An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

5.  Loss of the interaction between estradiol and insulin-like growth factor I in brain endothelial cells associates to changes in mood homeostasis during peri-menopause in mice.

Authors:  Victor Munive; Jonathan A Zegarra-Valdivia; Raquel Herrero-Labrador; Ana M Fernandez; Ignacio Torres Aleman
Journal:  Aging (Albany NY)       Date:  2019-01-11       Impact factor: 5.682

Review 6.  Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Authors:  Paola Rampelotto Ziani; Jacson Gabriel Feiten; Jéferson Ferraz Goularte; Rafael Colombo; Bárbara Antqueviezc; Luiza Paul Géa; Adriane Ribeiro Rosa
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

Review 7.  Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.

Authors:  Kun-Yu Tu; Ming-Kung Wu; Yen-Wen Chen; Pao-Yen Lin; Hung-Yu Wang; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

8.  Neurotrophic factors in bipolar disorders patients with manic episode

Authors:  Özgür Korhan Tunçel; Gökhan Sarisoy; Eda Çetin; Ebru Kaynar Tunçel; Birşen Bilgici; Arzu Karaustaoğlu
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

9.  Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons.

Authors:  M Estrella Fernández de Sevilla; Jaime Pignatelli; Jonathan A Zegarra-Valdivia; Pablo Mendez; Angel Nuñez; Ignacio Torres Alemán
Journal:  Mol Psychiatry       Date:  2022-02-03       Impact factor: 13.437

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.